🏛️ Verified NIH Record • Updated 2026-04-06
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus (NCT07205900)
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Hanmi Pharmaceutical Company Limited
🩺 Plain-English Summary (8th-Grade Level)
This Study is a Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus.
Who can join: Review the eligibility criteria below.
Location: ProSciento Inc — Chula Vista, California
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (14 Sites)
- ProSciento Inc — Chula Vista, California
- Accellacare of Duly - Duly Oak Lawn — Oak Lawn, Illinois
- Accellacare of McFarland — Ames, Iowa
- Accellacare of Cary - Cary Medical Group — Cary, North Carolina
- Accellacare of Hickory — Hickory, North Carolina
- Raleigh Medical Group, P.A. — Raleigh, North Carolina
- Accellacare of Piedmont - Piedmont HealthCare — Statesville, North Carolina
- Accellacare of Wilmington, LLC — Wilmington, North Carolina
- Accellacare of Winston Salem — Winston-Salem, North Carolina
- Accellacare of Charleston — Mt. Pleasant, South Carolina
- Accellacare of Bristol-PAC of Tennessee — Bristol, Tennessee
- Bristol-Internal Medicine and Pediatric Associates of Bristol, P.C. — Bristol, Tennessee
- Texas Clinical Research Institute — Arlington, Texas
- Velocity Clinical Research, Dallas — Dallas, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obese
- Aleniglipron Phase 2 in Type 2 Diabetes Mellitus — Anniston, Alabama
- A Study of Distal Jejunal-release Dextrose in Obese Participants — Tbilisi,
- Brain Fuel - Morning Nutrition and Cognitive Function — Little Rock, Arkansas
- A Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults — London, Ontario
- Dynamo: a Tailored Lifestyle Promotion Intervention Among Pediatric Patients With Cardiometabolic Risk Factors — Montreal, Quebec
Explore by condition: All Obese clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.